Helix BioPharma Corp. (HBPCF)
OTCMKTS · Delayed Price · Currency is USD
0.6000
0.00 (0.00%)
Jul 30, 2025, 8:00 PM EDT
Accolade Market Cap
Helix BioPharma has a market cap or net worth of $58.04 million as of August 1, 2025. Its market cap has increased by 84.77% in one year.
Market Cap
58.04M
Enterprise Value
57.52M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.60
Market Cap Chart
Since August 15, 1995, Helix BioPharma's market cap has increased from 6.90M to 58.04M, an increase of 741.62%. That is a compound annual growth rate of 7.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 57.33M | 89.08% |
| Dec 31, 2024 | 30.32M | -11.99% |
| Dec 29, 2023 | 34.45M | 8.43% |
| Dec 30, 2022 | 31.77M | -5.92% |
| Dec 31, 2021 | 33.77M | -36.31% |
| Dec 31, 2020 | 53.03M | -58.92% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.81B |
| Veradigm | 789.71M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 584.53M |
| Glass House Brands | 415.24M |
| Nika Pharmaceuticals | 366.89M |
| Northwest Biotherapeutics | 349.54M |
| CytoDyn | 341.59M |